Cargando…

Clinical Characteristics and Outcomes of Healthcare-Associated Hematogenous Vertebral Osteomyelitis

BACKGROUND: The incidence of hematogenous vertebral osteomyelitis (HVO) has increased over recent years, likely due to longer life expectancies, higher prevalence of chronic disease, and more effective diagnostic techniques. Recently, healthcare-associated infections, such as catheter-related and pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Ki-Ho, Lee, Yu-Mi, Moon, Song Mi, Park, Seong Yeon, Cho, Oh-Hyun, Lee, Mi Suk, Bae, In-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631817/
http://dx.doi.org/10.1093/ofid/ofx163.054
_version_ 1783269566309203968
author Park, Ki-Ho
Lee, Yu-Mi
Moon, Song Mi
Park, Seong Yeon
Cho, Oh-Hyun
Lee, Mi Suk
Bae, In-Gyu
author_facet Park, Ki-Ho
Lee, Yu-Mi
Moon, Song Mi
Park, Seong Yeon
Cho, Oh-Hyun
Lee, Mi Suk
Bae, In-Gyu
author_sort Park, Ki-Ho
collection PubMed
description BACKGROUND: The incidence of hematogenous vertebral osteomyelitis (HVO) has increased over recent years, likely due to longer life expectancies, higher prevalence of chronic disease, and more effective diagnostic techniques. Recently, healthcare-associated infections, such as catheter-related and procedure-related bloodstream infections, also increase the risk of HVO. The aim of our study was to evaluate the clinical characteristics and outcomes of healthcare-associated HVO (HCA-HVO). METHODS: We conducted a retrospective chart review of adult patients with microbiologically diagnosed HVO from five tertiary-care hospitals over 8-year period. HCA-HVO was defined as onset of symptoms after 1 month of hospitalization or within 6 months after hospital discharge, or ambulatory manipulations in the 6 months before the diagnosis [Pigrau et al. Medicine (Baltimore) 2015; 94:e365]. We compared the clinical characteristics and outcomes of HCA-HVO with community-acquired HVO (CA-HVO) cases. RESULTS: In total, 358 patients with microbiologically diagnosed HVO were included in final analysis. Of these 358 cases, 256 (63.1%) were CA-HVO and 132 (36.9%) were HCA-HVO according to the predefined criteria. The main causative pathogens identified were methicillin-susceptible Staphylococcus aureus (32%), followed by methicillin-resistant S. aureus (MRSA) (26%), aerobic gram-negative bacteria (24%), and Streptococcus species (11%). Compared with CA-HVO cases, patients with HCA-HVO had more neoplasm (13.6% vs. 5.8%, P = 0.01) and end-stage renal disease (8.3% vs. 2.2%, P = 0.007). MRSA was more frequent pathogens in HCA-HVO cases than in CA-HVO (37.1% vs. 17.7%, P = 0.01). Patients with HCA-HVO were more likely to be have the higher rates of persistent bacteremia for ≥7 days (24.2% vs. 15.5%, P = 0.04), 1-year mortality (18.2% vs. 11.5%, P = 0.08) and 1-year relapse (12.1% vs. 6.2%, P = 0.051). CONCLUSION: In this study, more than one-third of HVO is health care associated. Patients with HCA-HVO were more likely to have underlying illness, and their causative pathogens were more frequently MRSA. Outcomes of HCA-HVO were poorer, which require prevention measures and early diagnosis. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5631817
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56318172017-11-07 Clinical Characteristics and Outcomes of Healthcare-Associated Hematogenous Vertebral Osteomyelitis Park, Ki-Ho Lee, Yu-Mi Moon, Song Mi Park, Seong Yeon Cho, Oh-Hyun Lee, Mi Suk Bae, In-Gyu Open Forum Infect Dis Abstracts BACKGROUND: The incidence of hematogenous vertebral osteomyelitis (HVO) has increased over recent years, likely due to longer life expectancies, higher prevalence of chronic disease, and more effective diagnostic techniques. Recently, healthcare-associated infections, such as catheter-related and procedure-related bloodstream infections, also increase the risk of HVO. The aim of our study was to evaluate the clinical characteristics and outcomes of healthcare-associated HVO (HCA-HVO). METHODS: We conducted a retrospective chart review of adult patients with microbiologically diagnosed HVO from five tertiary-care hospitals over 8-year period. HCA-HVO was defined as onset of symptoms after 1 month of hospitalization or within 6 months after hospital discharge, or ambulatory manipulations in the 6 months before the diagnosis [Pigrau et al. Medicine (Baltimore) 2015; 94:e365]. We compared the clinical characteristics and outcomes of HCA-HVO with community-acquired HVO (CA-HVO) cases. RESULTS: In total, 358 patients with microbiologically diagnosed HVO were included in final analysis. Of these 358 cases, 256 (63.1%) were CA-HVO and 132 (36.9%) were HCA-HVO according to the predefined criteria. The main causative pathogens identified were methicillin-susceptible Staphylococcus aureus (32%), followed by methicillin-resistant S. aureus (MRSA) (26%), aerobic gram-negative bacteria (24%), and Streptococcus species (11%). Compared with CA-HVO cases, patients with HCA-HVO had more neoplasm (13.6% vs. 5.8%, P = 0.01) and end-stage renal disease (8.3% vs. 2.2%, P = 0.007). MRSA was more frequent pathogens in HCA-HVO cases than in CA-HVO (37.1% vs. 17.7%, P = 0.01). Patients with HCA-HVO were more likely to be have the higher rates of persistent bacteremia for ≥7 days (24.2% vs. 15.5%, P = 0.04), 1-year mortality (18.2% vs. 11.5%, P = 0.08) and 1-year relapse (12.1% vs. 6.2%, P = 0.051). CONCLUSION: In this study, more than one-third of HVO is health care associated. Patients with HCA-HVO were more likely to have underlying illness, and their causative pathogens were more frequently MRSA. Outcomes of HCA-HVO were poorer, which require prevention measures and early diagnosis. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631817/ http://dx.doi.org/10.1093/ofid/ofx163.054 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Park, Ki-Ho
Lee, Yu-Mi
Moon, Song Mi
Park, Seong Yeon
Cho, Oh-Hyun
Lee, Mi Suk
Bae, In-Gyu
Clinical Characteristics and Outcomes of Healthcare-Associated Hematogenous Vertebral Osteomyelitis
title Clinical Characteristics and Outcomes of Healthcare-Associated Hematogenous Vertebral Osteomyelitis
title_full Clinical Characteristics and Outcomes of Healthcare-Associated Hematogenous Vertebral Osteomyelitis
title_fullStr Clinical Characteristics and Outcomes of Healthcare-Associated Hematogenous Vertebral Osteomyelitis
title_full_unstemmed Clinical Characteristics and Outcomes of Healthcare-Associated Hematogenous Vertebral Osteomyelitis
title_short Clinical Characteristics and Outcomes of Healthcare-Associated Hematogenous Vertebral Osteomyelitis
title_sort clinical characteristics and outcomes of healthcare-associated hematogenous vertebral osteomyelitis
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631817/
http://dx.doi.org/10.1093/ofid/ofx163.054
work_keys_str_mv AT parkkiho clinicalcharacteristicsandoutcomesofhealthcareassociatedhematogenousvertebralosteomyelitis
AT leeyumi clinicalcharacteristicsandoutcomesofhealthcareassociatedhematogenousvertebralosteomyelitis
AT moonsongmi clinicalcharacteristicsandoutcomesofhealthcareassociatedhematogenousvertebralosteomyelitis
AT parkseongyeon clinicalcharacteristicsandoutcomesofhealthcareassociatedhematogenousvertebralosteomyelitis
AT choohhyun clinicalcharacteristicsandoutcomesofhealthcareassociatedhematogenousvertebralosteomyelitis
AT leemisuk clinicalcharacteristicsandoutcomesofhealthcareassociatedhematogenousvertebralosteomyelitis
AT baeingyu clinicalcharacteristicsandoutcomesofhealthcareassociatedhematogenousvertebralosteomyelitis